Dimitrios Vassilopoulos, MD
SHORT CURRICULUM VITAE Vassilopoulos Dimitrios, MD Associate Professor of Medicine – Rheumatology, Athens University School of Medicine, 2nd Department of Medicine and Laboratory Hippokration General Hospital 114 Vass.Sophias Ave. 115 27 Athens, GREECE Phone:+ 30-213-2088516, Fax:+ 30-213-2088399 e-mail:
[email protected] MEDICAL EDUCATION 1983-1989 M.D., Athens University School of Medicine, Athens, Greece CURRENT POSITION:
POSTGRADUATE TRAINING – RESEARCH/PROFESSIONAL EXPERIENCE 1991-1992 Resident in Internal Medicine, 401 General Army Hospital, Athens, Greece 1992-1994 Research Fellow in Clinical Immunology, Department of Clinical Investigation, Walter Reed Army Medical Center, Washington, DC 1994-1997 Resident in Internal Medicine, Emory University, Atlanta, GA, USA 1997-1999 Fellow in Rheumatology, The Cleveland Clinic Foundation, Cleveland OH, USA 1999- 2003 Research and Clinical Associate, 2nd Department of Medicine and Laboratory, Hippokration General Hospital, Athens University School of Medicine, Athens, Greece 2000- 2003 Attending in Internal Medicine and Consultant Rheumatologist, Department of Medicine, Henry Dunant Hospital, Athens, Greece 2002-2003 Vice Chairman, 3rd Department of Internal Medicine, Henry Dunant Hospital, Athens, Greece 2003-2010 Assistant Professor of Medicine-Rheumatology, Athens University School of Medicine, 2nd Department of Medicine and Laboratory, Hippokration General Hospital, Athens, Greece 2010-present Associate Professor of Medicine-Rheumatology, Athens University School of Medicine, 2nd Department of Medicine and Laboratory, Hippokration General Hospital, Athens, Greece BOARD CERTIFICATION - LICENCES 1990 Greek Medical License, Athens, Greece 1997 Board Certification in Internal Medicine, USA 1997 Medical License, Georgia, USA 1999 Board Certification in Rheumatology, USA 2000 Board Certification in Rheumatology, Greece PROFESSIONAL MEMBERSHIPS 1990 Athens Medical Association 1994 American College of Physicians (ACP) 1997 American College of Rheumatology (ACR) 2002 Greek Society of Rheumatology (ERE)-Secretary General 2004-06 2003 European League Against Rheumatism (EULAR) 2005 Helenic Society for the Study of Liver Diseases 1
Dimitrios Vassilopoulos, MD
2013
Federation of Clinical Immunology Societies (FOCIS)
EDITORIAL WORK Reviewer for International Journals 41 Allergy and Asthma Proceedings, American Journal of Gastroenterology, Annals of Rheumatic Diseases, Antimicrobial Agents and Chemotherapy, Antiviral Research, Arthritis and Rheumatism, Arthritis Care and Research, Arthritis Research and Therapy, Clinical and Diagnostic Laboratory Immunology, Clinical and Experimental Dermatology, Clinical and Experimental Immunology, Clinical and Experimental Rheumatology, Clinical Drug Investigation, Clinical Immunology Immunopathology (Clinical Immunology), Clinical Rheumatology, European Cytokine Network, European Journal of Clinical Investigation, European Journal of Gastroenterology and Hepatology, Expert Opinion in Biological Therapy, Expert Opinion on Drug Safety Infection and Immunity, Intervirology, Journal of Clinical and Experimental Hepatology, Journal of Clinical Microbiology, Journal of Clinical Rheumatology, Journal of Hepatology, Journal of Infection, Journal of Investigative Medicine, Journal of Rheumatology, ,Journal of the European Academy of Dermatology and Venereology, Journal of Viral Hepatitis, Journal of Virology, Lancet, Liver International, Medicine, Nature Reviews Rheumatology, Pharmacoepidemiology and Drug Safety, PLOS ONE, Scandinavian Journal of Rheumatology Member of the Editorial Board of International Journals 3 Annals of Rheumatic Diseases (2012-), Clinical and Diagnostic Laboratory Immunology (2003-2011), Clinical Immunology (2005-)
RESEARCH 2392 (Google Scholar) 17 (Scopus) 206
Number of citations
H-index Personal Impact Factor PUBLICATIONS Publications in International Peer-Reviewed Journals
1. 2.
3. 4. 5.
6. 7. 8.
9.
71
Vasileiou P, Tsioufis C, Lazaros G, Hadziyannis E, Kasiakogias A, Stefanadis C, Kallikazaros I, Vassilopoulos D. Interleukin-8 as a predictor of acute idiopathic pericarditis recurrences. A pilot study. Int J Card. (in press) Kambas K, Chrysanthopoulou A, Vassilopoulos D, Apostolidou E, Skendros P, Girot A, Arelaki S, Froudarakis M, Giatromanolaki A, Sidiropoulos P, Koffa M, Boumpas DT, Ritis K, Mitroulis I. Induction of tissue factor expression in neutrophil extracellular traps and neutrophil-derived microparticles in ANCA associated vasculitis. Ann Rheum Dis (in press) Fanouriakis A, Vassilopoulos D., Repa A, Boumpas DT, Sidiropoulos P. Hepatitis B reactivation following treatment with abatacept in a patient with past hepatitis B virus infection. Rheumatology 2014;53:195-6 Hadziyannis SJ, Vassilopoulos D, Hadziyannis E.: The natural course of chronic hepatitis B virus infection and its management. Adv Pharmacol 2013;67:247-91 Minopetrou M, Hadziyannis E, Deutsch M, Tampaki M, Georgiadou A, Dimopoulou E, Vassilopoulos D, Koskinas J. HCV Related Cryoglobulinemia: Cryoglobulin Type and anti-HCV Profile. Clin Vaccine Immunol 2013;20:698-703 Vassilopoulos D. and Calabrese LH: Viral Hepatitis: Review of Arthritic Complications and Therapy for Arthritis in the Presence of Active HBV/HCV. Curr Rheum Rep 2013;15:319Mitroulis I, Hatzara C, Kandili A, Hadziyannis E, Vassilopoulos D. Long-term safety of rituximab in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection. Ann Rheum Dis 2013;72:308-10 Hadziyannis SJ, Sevastianos V, Rapti I, Vassilopoulos D, Hadziyannis E, Sustained Responses and Loss of HBsAg in HBeAg-Negative Patients with Chronic Hepatitis B Who Stop Long-Term Treatment with Adefovir. Gastroenterology 2012;143:629-36 Vassilopoulos D, Papatheodoridis GV. The safety of anti-TNF therapy in patietns with hepatitis B and C virus infection. Int J Clin Rheumatol 2012;7:191-6 2
Dimitrios Vassilopoulos, MD
10. Vassilopoulos D, Lazaros G, Vasileiou P,Tsioufis C, Stefanadis C, Pectasidis D. Successful treatment of adult patients with idiopathic recurrent pericarditis with an interleukin-1 receptor antagonist (Anakinra). Int J Card 2012;160:66-68 11. Vassilopoulos D, Calabrese LH: Management of rheumatic disease with comorbid HBV or HCV infection. Nat Rev Rheumatol 2012;8:348-57 12. Hadziyannis SJ, Vassilopoulos D: What Should Be the Endpoints of Oral Therapy in HBeAg-positive Versus HBeAg-negative Patients with Chronic Hepatitis B. Curr Hepatitis Rep 2012;11:65-9 13. Vassilopoulos D, Tsikrika S, Hatzara C, Podia V, Kandili A, Stamoulis N, Hadziyannis E. Comparison of two interferon-gamma release assays and tuberculin skin testing for tuberculosis screening in a cohort of rheumatic patients starting anti-TNF therapy. Clinical Vaccine Immunology 2011; 18:2102-08 14. Vassilopoulos, D. Should we routinely treat patients with autoimmune/rheumatic diseases and chronic hepatitis B virus infection starting biologic therapies with antiviral agents? Yes. Eur. J Intern. Med. 2011;22(6): 572575 15. Deutsch M, Papadopoulos N, Manolakopoulos S, Hadziyanni E, Vassilopoulos D: Fatal hepatitis B reactivation due to a lamivudine mutant undetectable initial viral load. Eur J Gastroenterol & Hepatol 2011;23:109 16. Markoussis-Mavrogeni S, Vassilopoulos D. Is there a place for Cardiovascular Magnetic Resonance Imaging in the evaluation of cardiovascular involvement in Rheumatic Diseases? Seminars in Arhtritis and Rheumatism 2011; 41(3): 488-496 17. Dalagiorgou G., Vassilaki N., Foka P., Boumlic A., Kakkanas A. Kochlios E., Khalili S., Aslanoglou E., Veletza S., Orfanoudakis G., Vassilopoulos D., Hadziyannis SJ, Koskinas J., and Mavromara P. High Levels of HCV core+1 Antibodies in HCV Patients with Hepatocellular Carcinoma. Journal of General Virology 2011;92:1343-51 18. Tsioufis C, Lazaros G, Vassilopoulos D, Vasileiou P, Stefanadis C. Acute Pericarditis Masquerading as ST Elevation Myocardial Infarction. Am J Med. 2010;123(11):996-8. 19. Vassilopoulos D, Apostolopoulou A, Hadziyannis E, Papatheodoridis GV, Manolakopoulos S, Koskinas J, Manesis EK, Archimandritis AI. Long term safety of anti-TNF treatment in rheumatic patients with chronic or resolved hepatitis B virus infection. Ann Rheum Dis. 2010;69(7):1352-5 20. Vassilopoulos D., Sialevris K., Malahtari S., Deutsch M., Manolakopoulos S., Archimandritis A.J. Subacute thyroiditis presenting as fever of unknown origin in a patient with rheumatoid arthritis under etanercept treatment. Journal of Clinical Rheumatology 2010;16:88-9 21. Vassilopoulos D, Manolakopoulos S. Rheumatic manifestations of hepatitis. Curr Opin Rheumatol 2010;22(1):91-96 22. Hadziyannis SJ, Hadziyannis E., Vassilopoulos D.. Quantitative HBsAg titer as predictor of response to therapy. Current Hepatitis Reports 2009;8(4):169-72 23. Vassilopoulos D., Hadziyannis SJ: Current Treatment Options for HBV Infection Current Hepatitis Reports 2009;8(1):26-30 24. Hadziyannis SJ, Vassilopoulos D. New therapies in chronic hepatitis B. Current Hepatitis Reports 2008;7:173-8 25. Panagiotakis SH, Perysinakis GS, Kritikos H, Vassilopoulos D, Vrentzos G, Linardakis M, Bertsias G, Glaser K, Daphnis E, Boumpas DT. The epidemiology of primary systemic vasculitides involving small vessels in Crete (southern Greece): a comparison of older versus younger adult patients. Clin Exp Rheumatol. 2009;27:409-15 26. Tsikrikas S, Manolakopoulos S, Deutsch M, Alexakis G, Sialevris K, Giannopoulos D, Vassilopoulos D, Archimandritis AJ. Unusual combination of paraneoplastic manifestations in a patient with metastatic gastrointestinal stromal tumor (GIST). Scand J Gastroenterol. 2008;43(8):1012-5 27. Hadziyannis SJ, Vassilopoulos D. Telbivudine in the treatment of chronic hepatitis B. Expert Rev Gastroenterol Hepatol. 2008 Feb;2(1):13-22 28. Raptopoulou A, Sidiropoulos P, Siakka P, Boki K, Drosos AA, Aslanidis S, Karras D, Pikazis D, Vassilopoulos D, Karassa F, Boumpas DT; Hellenic working group of the 3E Initiative in Rheumatology. Evidence-based recommendations for the management of ankylosing spondylitis: results of the Hellenic working group of the 3E Initiative in Rheumatology. Clin Exp Rheumatol. 2008;26(5):784-92 29. Koutsogeorgopoulou L, Antoniadis C, Vassilopoulos D, Kassimos D. Preventive influenza vaccination for patients with rheumatoid arthritis. A need for an international campaign. Clin Rheumatol. 2009;28(1):103-4 30. Vassilopoulos D, Calabrese LH. Virally associated arthritis 2008: clinical, epidemiologic, and pathophysiologic considerations. Arthritis Res Ther. 2008;10(5):215 3
Dimitrios Vassilopoulos, MD
31. Vassilopoulos D, Rapti I, Nikolaou M, Hadziyannis E, Hadziyannis SJ. Cellular immune responses in hepatitis B virus e antigen negative chronic hepatitis B. Journal of Viral Hepatitis 2008;15:817-26 32. Deutsch M, Vassilopoulos D, Sevastos N, Papadimitriou A, Vasiliou K, Archimandritis AJ. Severe rhabdomyolysis with hypoglycemia in an adult patient with carnitine palmitoyltransferase II deficiency. European Journal of Internal Medicine 2008;19:289-91 33. Vassilopoulos D, Stamoulis N, Hadziyannis E, Archimandritis AI. Usefulness of an enzyme linked immunospot assay (ELISPOT) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment. Journal of Rheumatology 2008;35:1271-6 34. Hadziyannis E, Manesis E, Vassilopoulos D, Georgiou A, Archimandritis A. Performance Characteristics of IgM anti-HBc Measurement by Microparticle Enzyme and Chemilluminescence Immunoassays in Sera of Patients with HbeAg-Negative Chronic Hepatitis B Virus Infection. Clin Vaccine Immunol 2008;15:385-87 35. Tsikrikas S, Sialevris K, Tsochatzis E, Deutsch M, Vassilopoulos D, Vgontza N, Archimandritis AJ. Acute splenic sequestration crisis (ASSC) in an adult patient with beta-thalassemia sickle cell disease: a lifethreatening complication. Ann Hematol 2008;87:499-500 36. Tsiachris D, Deutsch M, Vassilopoulos D, Zafiropoulou R, Archimandrirtis AJ. Sensorineural hearing loss complicating severe rickettsial diseases: Report of two cases. Journal of Infection 2008;56(1):74-76 37. Vassilopoulos D, Calabrese LH. Risks of immunosuppressive therapies including biologic agents in patients with rheumatic diseases and co-existing chronic viral infections. Curr Opin Rheumatol 2007; 19:619-625 38. Vassilopoulos D. Cytochrome P450 enzyme polymorphisms and treatment-related ovarian toxicity in patients with SLE. Nat Clin Pract Rheumatol 2007; 3:492-493 39. Tsochatzis E., Vassilopoulos D., Manesis EK, Papatheodoridis G, Bousiotou A., Hadziyannis E., Archimandritis AJ: First appearance of Crohn's disease following infliximab therapy for spondyloarthropathy. Scand J Gastroenterol 2007; 42(6):784-785 40. Deutsch M., Manesis EK, Hadziyannis E, Vassilopoulos D, Archimandritis AJ. Thrombotic thrombocytopenic purpura with fatal outcome in a patient with chronic hepatitis C treated with pegylated interferon – a/2b. Scand J Gastroenterol 2007; 42:408-409 41. Vassilopoulos D., Mantzoukis D.: Dialogue between the brain and the immune system in inflammatory arthritis. Annals of NY Academy of Sciences 2006;1088:132-8 42. Tsochatzis Ε., Vassilopoulos D., Deutsch Μ., Asvesti C., Sevastos N., Archimandritis A.J. Myelodysplastic syndrome presenting as acquired ichthyosis. European Journal of Internal Medicine 2006; 17: 368-9 43. Calabrese LH, Zein N, Vassilopoulos D. Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: Assessment and preventive strategies. Annals of Rheumatic Diseases 2006;65:983-9 44. Tsochatzis E., Vassilopoulos D., Deutsch M., Filiotou A., Tasidou A., Archimandritis AJ: Angioimmunoblastic T-cell lymphoma associated arthritis:Case report and literature review. Journal of Clinical Rheumatology 2005; 11: 326-28 45. Vassilopoulos D. and Calabrese LH: Extrahepatic immunologic complications of hepatitis C virus infection. AIDS 2005; 19 (Suppl 3): S123-27 46. Deutsch M, Koskinas J, Tzannos K, Vassilopoulos D, Mailis A, Tolis G et al. Hashimoto encephalopathy with pegylated interferon alfa-2b and ribavirin. Ann Pharmacother 2005; 39:1745-1747 47. Alexopoulou A, Dourakis SP, Stamoulis ND, Vassilopoulos D, Archimandritis AJ. Poststreptococcal reactive arthritis with thoracic spine involvement in an adult. Journal of Rheumatology 2005; 32:2002-2005 48. Calabrese LH, Zein N, Vassilopoulos D. Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection. Ann Rheum Dis 2004; 63 Suppl 2:ii18-ii24. 49. Papatheodoridis G.V., Papadelli D., Cholongitas E., Vassilopoulos D., Mentis A., Hadziyannis S.J.: Effect of Helicobacter pylori infection on the risk of upper gastrointestinal bleeding in users of non-steroidal antiinflammatory drugs. American Journal of Medicine 2004; 116:601-605 50. Vassilopoulos D., Younossi Z.M., Hadziyannis E., Boparai N., Yen Lieberman B., Hsi E., Villa-Forte A., Ball E., Kimberly R.P., Calabrese L.H. Study of host and virological factors of patients with chronic HCV infection and associated laboratory or clinical autoimmune manifestations. Clin Exp Rheumatol 2003; 21: (Suppl. 32): S101-S111 51. Hadziyannis SJ, Papatheodoridis GV, Vassilopoulos D: Precore mutant chronic hepatitis B- Approach to management. Medscape General Medicine, 2003 4
Dimitrios Vassilopoulos, MD
52. Vassilopoulos D. and Calabrese LH: Rheumatic manifestations of Hepatitis C infection. Current Rheumatology Reports 2003;5:200-204 53. Vassilopoulos D., Niles J.L., Villa-Forte A., Arroliga A.C., Sullivan E.J., Merkel P.A., Hoffman G.S.: Prevalence of antineutrophil cytoplasmic antibodies (ANCA) in patients with various pulmonary diseases or multiorgan dysfunction. Arthritis Care and Research 2003;49:151-155 54. Hadziyannis S.J., Papatheodoridis G.V., Vassilopoulos D. : Treatment of HBeAg Negative Chronic Hepatitis B. Seminars In Liver Disease 2003;23:81-88 55. Vassilopoulos D. and Calabrese LH: Hepatitis C virus infection and vasculitis. Implications of antiviral and immunosuppressive therapies Arthritis and Rheumatism 2002;46:585-597 56. Μichopoulos S, Tsibouris P., Sotiropoulou M., Petraki K., Vassilopoulos D., Kralios N.: Watermelon stomach and Familial Mediterranean Fever. American Journal of Gastroenterology 2001;96:2512-3 57. Hadziyannis S.J., and Vassilopoulos D.: Ηepatitis B e antigen negative chronic hepatitis B infection Ηepatology 2001;34:617-24 58. Hadziyannis S.J., and Vassilopoulos D.: Immunopathogenesis of hepatitis B e antigen negative chronic hepatitis B infection. Antiviral Research 2001;52:91-98 59. Hadziyannis S.J., and Vassilopoulos D.: Complex management issues: Management of HCV in the atypical patient. Bailleres Best Practice Res in Clinical Gastroenterology 2000; 14:277-291 60. Vassilopoulos D. and Hoffman G.S.: Clinical utility of antineutrophil cytoplasmic antibodies (ANCA) testing. Clinical Diagnostic and Laboratory Immunology 1999;6:645-51 61. Vassilopoulos D., Camisa C., Strauss R.M.: Selected drug complications and treatment conflicts in the presence of coexistent diseases. Rheumatic Disease Clinics of North America 1999;25: 745-77 62. Vassilopoulos D. and Calabrese L.H.: Rheumatological manifestations of HIV-1 and HTLV-I infections. Cleveland Clinic Journal of Medicine 1998; 64: 436-41 63. Vassilopoulos D., Waltuck J., Clarke G., Farhi D.C., Williams J., Fanucchi M.P.: Reversible Epstein-Barr virus associated T cell Non-Hodgkin’s lymphoma in a patient with rheumatoid arthritis on chronic immunosuppressive therapy. Journal of Rheumatology 1998;25:389-91 64. Liossis S.N.C., Vassilopoulos D., Kovacs B. and Tsokos G.C.: Immune cell biochemical abnormalities in systemic lupus erythematosus. Clinical and Experimental Rheumatology 1997;15: 677-84, 65. Vassilopoulos D., Zurier R.B., Rossetti R.G., Tsokos G.C.: Gammalinolenic acid and dihomo-g-linolenic acid supress CD3 mediated signal transduction pathway in human T cells. Clinical Immunology Immunopathology 1997, 83:237-44 66. Vassilopoulos D., Chalasani P., Jurado R.L., Workowski K., Agudelo C.A.: Musculoskeletal infections in patients with human immunodeficiency virus infection. Medicine 1997; 76:284-94 67. Kovacs B., Vassilopoulos D., Vogelgesang S.A., and Tsokos G.C.: Defective CD3-mediated cell death in activated T cells from patients with Systemic Lupus Erythematosus. Role of decreased intracellular TNF-alpha. Clinical Immunology Immunopathology 1996, 81:293-302, 68. Hornstein E.H., Vassilopoulos D., Thomas D.E., Friedman F.K., Tsokos G.C.: Modulation of human Tlymphocyte plasma membrane permeability by imidazole antimycotics. Immunopharmacology and Immunotoxicology 1996, 18:237-4 69. Vassilopoulos D., Kovacs B., Tsokos G.C.: T cell receptor/CD3 complex-mediated signal transduction pathway in T cells and T cell lines from patients with systemic lupus erythematosus. Journal of Immunology 1995, 155:2269-2281 70. Vassilopoulos D., Smallridge R.C., Tsokos G.C.: Effects of an aminosteroid inhibitor of phospholipase Cdependent processes on TCR-mediated signal transduction pathway in human T cells. Clinical Immunology Immunopathology 1995, 77:59-68 71. Karras D., Karargyris G., Vassilopoulos D., Karatzetzos C.: Reflex sympathetic dystrophy syndrome and osteogenesis imperfecta. A report and review of the literature. Journal of Rheumatology, 1993; 20: 162-64
Chapters in International Books 1. 2. 3.
19
Vassilopoulos D. and Calabrese L.H.: Virus-associated vasculitides: clinical aspects. In: Hoffman G.S and Weyand C. (eds.). Inflammatory Diseases of Blood Vessels, Marcel Dekker, New York, 2001, 565-599. Vassilopoulos D and Calabrese L.H.: Vasculitis. In: Tsokos G.C., Moreland LW, Kammer G.M., Pelletier J.P., Pelletier J.M., Gay S. (eds). Modern Therapeutics in Rheumatic Diseases, Humana Press Inc., 2001, 359-388 Vassilopoulos D., and Hadziyannis S.J.: Future antiviral and immunomodulatory therapy options for chronic hepatitis B. In: Moreno-Otero R., Albillos A., Garcia-Monzen C.(eds): Immunology and the Liver: Cytokines, Accion Medica, Madrid, 2002, 325-336. 5
Dimitrios Vassilopoulos, MD
4.
5. 6. 7. 8.
9.
10.
11. 12. 13. 14.
15.
16. 17. 18. 19.
Vassilopoulos D and Calabrese L.H.: Rheumatic aspects of human immunodeficiency virus infection and other immunodeficient states. In: Hochberg M.C., Silman A.J., Smolen, J.S., Weinblatt M.E., Weisman M.H. (eds). Rheumatology, 3rd edition, Mosby, 2003, 1115-29. Hadziyannis SJ, Vassilopoulos D., Papatheodoridis G.: Hepatitis D. In: Knawy B, Shiffman ML, Wiesner R (eds): Hepatology: A Practical Approach, Elsevier Science BV, Amsterdam, 2004, 101-109 Vassilopoulos D.: Hepatitis C infection and vasculitis. In: Shoenfeld Y., Rose N.R. (eds): Infection and Autoimmunity, Elsevier Science BV, Amsterdam, 2004, 189-200 Vassilopoulos D. and Hadziyannis SJ: Clinical features of hepatitis D virus. In: Handa H., Yamaguchi Y. (eds): Hepatitis Delta Virus, Landes Bioscience/Eurekah.com, Georgetown, TX. USA, 2006, 76-80 Vassilopoulos D.: Rheumatic manifestations of acute and chronic viral arthritis. In: Imboden JB, Hellmann DB, Stone JH (eds): Current Diagnosis and Treatment in Rheumatology (LANGE Current Series), McGraw Hill, 2007, 388-395 Ghanem KG, Vassilopoulos D., Gebo KA: Evaluation of rheumatic complaints in patients with HIV. In: Imboden JB, Hellmann DB, Stone JH (eds): Current Diagnosis and Treatment in Rheumatology (LANGE Current Series), McGraw Hill, 2007, 396-404 Vassilopoulos D and Calabrese L.H.: Rheumatic aspects of HIV infection and other immunodeficient states. In: Hochberg M.C., Silman A.J., Smolen, J.S., Weinblatt M.E., Weisman M.H. (eds). Rheumatology, 4th edition, Mosby, 2008, 1055-69 Vassilopoulos D and Hadziyannis SJ: Chronic hepatitis B and D. In: Younossi ZM (ed). Practical Management of Liver Diseases. Cambridge University Press, 2008, 26-38 Vassilopoulos D.: Cryoglobulinemia. In: Pearls and myths in rheumatology. Stone JH (editor), Springer 2009;269-73 Vassilopoulos D and Calabrese L.H.: Rheumatologic aspects of viral infections. In: Hochberg M.C., Silman A.J., Smolen, J.S., Weinblatt M.E., Weisman M.H. (eds). Rheumatology, 5th edition, Elsevier Ltd. 2011 Vassilopoulos D and Manolakopoulos S.: The complex management of viral-related autoimmune diseases. In: Khamashta MA, Ramos -Casals M (eds). Autoimmune Diseases: Complex and acute situations, Springer Science +Business Media, Inc. New York 2011;345-357 Vassilopoulos D. and Calabrese LH: Virus-Associated Vasculitides. In: Gary S. Hoffman, Cornelia M. Weyand, Carol A. Langford, Jörg J. Goronzy. Inflammatory Diseases of Blood Vessels, Second Edition. Blackwell Publishing Ltd. 2012;369-79 Vassilopoulos D and Calabrese L.H.: Rheumatologic aspects of viral infections. In: Hochberg M.C., Silman A.J., Smolen, J.S., Weinblatt M.E., Weisman M.H. (eds). Rheumatology, 6th edition (in press) Vassilopoulos D.: Vasculitis: Giant cell arteritis. In: Mackay IR, Rose NL (eds). Springer Science +Business Media, Inc. New York (in press) Vassilopoulos D.: Vasculitis: PMR. In: Mackay IR, Rose NL (eds). Springer Science +Business Media, Inc. New York (in press) Tsalapaki C and Vassilopoulos D.: Vasculitis: Primary central nervous system vasculitis. In: Mackay IR, Rose NL (eds). Springer Science +Business Media, Inc. New York (in press)
Invited speaker in International Meetings - Advances in the treatment of HCV-associated vasculitis. 64th Annual Scientific Meeting of the American College of Rheumatology (Vasculitis Study Group), Philadelphia, PA, USA, November 1, 2000. - Future antiviral and immunomodulatory therapy options for chronic hepatitis B. 2nd International Meeting on Immunology and the Liver: Cytokines, Madrid, Spain, June 6-7, 2002 - Cryoglobulinemic vasculitides: Evolving concepts. ΧΙ Mediterranean Congress of Rheumatology, Crete, September 23 2005 - Dialogue between the brain and the immune system in inflammatory arthritis. 6th Meeting of the International Society for Neuroimmunomodulation¨, Athens, Greece, 25-28 September 2005 - Vasculitis: Allergy Update in Greece, ACAAI-HSACI, Athens, September 6-9, 2006, Greece - Biologic agents and hepatitis B virus reactivation: Assessment and prevention. 70th Annual Scientific Meeting of the American College of Rheumatology-ACR, Washington, DC, USA, November 15, 2006 - Hepatitis and anti-TNFs: Do's and don’t's. Excellence in Rheumatology, Istanbul, February 17-19, 2011 - Managing HBV and HCV as comorbidity, Biologic Therapies V Summit , Cleveland, USA, May 2-4, 2013 - Managing HCV cryoglobulinemia, Biologic Therapies V Summit , Cleveland, USA, May 2-4 2013 - B cell depletion in vasculitis. Annual Meeting of the European Leaque Against Rheumatism (EULAR), Madrid 2013 6
Dimitrios Vassilopoulos, MD
Invited speaker in Greek Meetings
116
INTERNATIONAL COMMITTEE MEMBER 2006-07: Member of the Scientific Committee for the development of multi-national recommendations for the management of ankylosing spondylitis, 3E Initiative 2007-08: Member of the Scientific Committee for the development of multi-national recommendations for the use of methotrexate in rheumatic diseases, 3E Initiative 2009-12: Member of the Greek Steering Committee of the Multinational Committee of Treat To Target (T2T) for the treatment of Rheumatoid Arthritis 2009/2011: Expert of the European Research Council (ERC) for the Seventh Research Framework Programme 2010-12: Co-chair of the Abstract Selection Committee for the Infection-Related Rheumatic Disease Abstracts, Annual ACR/ARHP Sientific Meetings 2011: Member of the Scientific Committee of the 13th EULAR Postgraduate Course, 25 September-1 October, Dublin, Ireland 2013: Member of the Abstract Selection Committee for “Vasculitides”, EULAR Meeting 2013 2013-2016: Member of the EULAR Scientific Programme Committee 2014: Chair of the Abstract Selection Committee for “Infection-related rheumatic diseases” and “Rehabilitation”, EULAR Meeting 2014 ADMINISTRATIVE POSITIONS 12/00-05/03: 1/02 – 5/03 07/03-:
2011-13:
Director, Rheumatology Outpatient Clinic, Henry Dunant Hospital, Athens, Greece Vice Chairman, 3rd Department of Internal Medicine, Henry Dunant Hospital, Athens, Greece Director, Clinical Immunology-Rheumatology Unit, 2nd Department of Medicine and Laboratory, Hippokration General Hospital, Athens, Greece Responsible for: Outpatient Rheumatology Clinic (> 15,000 visits, 2003-today), inpatient hospital care and consultations for rheumatic patients, Infusion Center for biologics (> 4,500 infusions, 2007-today) Scientific Director for the “University Training Program in Rheumatology” for rheumatology trainees and young rheumatologists in Greece
7
